nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—hematologic cancer	0.139	1	CbGaD
Etravirine—CYP2C9—Bexarotene—hematologic cancer	0.0241	0.0439	CbGbCtD
Etravirine—ABCB1—Lenalidomide—hematologic cancer	0.0234	0.0426	CbGbCtD
Etravirine—CYP2C9—Idarubicin—hematologic cancer	0.0199	0.0364	CbGbCtD
Etravirine—CYP2C19—Bortezomib—hematologic cancer	0.0177	0.0323	CbGbCtD
Etravirine—CYP2C19—Thalidomide—hematologic cancer	0.0155	0.0282	CbGbCtD
Etravirine—CYP2C9—Bortezomib—hematologic cancer	0.0148	0.0269	CbGbCtD
Etravirine—CYP2C19—Teniposide—hematologic cancer	0.0148	0.0269	CbGbCtD
Etravirine—CYP3A4—Bexarotene—hematologic cancer	0.014	0.0255	CbGbCtD
Etravirine—ABCB1—Daunorubicin—hematologic cancer	0.0137	0.025	CbGbCtD
Etravirine—CYP2C19—Ifosfamide—hematologic cancer	0.0136	0.0248	CbGbCtD
Etravirine—ABCB1—Alitretinoin—hematologic cancer	0.0134	0.0245	CbGbCtD
Etravirine—CYP3A4—Busulfan—hematologic cancer	0.013	0.0237	CbGbCtD
Etravirine—CYP3A4—Lomustine—hematologic cancer	0.013	0.0237	CbGbCtD
Etravirine—CYP2C19—Imatinib—hematologic cancer	0.013	0.0237	CbGbCtD
Etravirine—CYP2C9—Thalidomide—hematologic cancer	0.0129	0.0234	CbGbCtD
Etravirine—CYP2C9—Teniposide—hematologic cancer	0.0123	0.0223	CbGbCtD
Etravirine—CYP3A4—Thiotepa—hematologic cancer	0.0116	0.0211	CbGbCtD
Etravirine—CYP2C9—Ifosfamide—hematologic cancer	0.0113	0.0206	CbGbCtD
Etravirine—CYP2C9—Imatinib—hematologic cancer	0.0108	0.0197	CbGbCtD
Etravirine—ABCB1—Imatinib—hematologic cancer	0.0105	0.0191	CbGbCtD
Etravirine—CYP2C9—Nilotinib—hematologic cancer	0.00983	0.0179	CbGbCtD
Etravirine—ABCB1—Nilotinib—hematologic cancer	0.00953	0.0174	CbGbCtD
Etravirine—ABCB1—Vinorelbine—hematologic cancer	0.00945	0.0172	CbGbCtD
Etravirine—CYP3A4—Methoxsalen—hematologic cancer	0.00902	0.0164	CbGbCtD
Etravirine—CYP3A4—Bortezomib—hematologic cancer	0.00858	0.0156	CbGbCtD
Etravirine—CYP2C19—Prednisone—hematologic cancer	0.00857	0.0156	CbGbCtD
Etravirine—ABCB1—Dasatinib—hematologic cancer	0.00843	0.0154	CbGbCtD
Etravirine—ABCB1—Mitoxantrone—hematologic cancer	0.00832	0.0152	CbGbCtD
Etravirine—CYP3A4—Daunorubicin—hematologic cancer	0.00821	0.015	CbGbCtD
Etravirine—ABCB1—Betamethasone—hematologic cancer	0.00742	0.0135	CbGbCtD
Etravirine—ABCB1—Gemcitabine—hematologic cancer	0.00735	0.0134	CbGbCtD
Etravirine—ABCB1—Prednisolone—hematologic cancer	0.00732	0.0133	CbGbCtD
Etravirine—CYP3A4—Cytarabine—hematologic cancer	0.00724	0.0132	CbGbCtD
Etravirine—CYP3A4—Teniposide—hematologic cancer	0.00713	0.013	CbGbCtD
Etravirine—ABCB1—Prednisone—hematologic cancer	0.00691	0.0126	CbGbCtD
Etravirine—CYP3A4—Ifosfamide—hematologic cancer	0.00658	0.012	CbGbCtD
Etravirine—ABCB1—Irinotecan—hematologic cancer	0.00655	0.0119	CbGbCtD
Etravirine—CYP3A4—Imatinib—hematologic cancer	0.00629	0.0115	CbGbCtD
Etravirine—CYP3A4—Ruxolitinib—hematologic cancer	0.00592	0.0108	CbGbCtD
Etravirine—ABCB1—Vinblastine—hematologic cancer	0.00583	0.0106	CbGbCtD
Etravirine—ABCB1—Vincristine—hematologic cancer	0.00573	0.0104	CbGbCtD
Etravirine—CYP3A4—Nilotinib—hematologic cancer	0.00571	0.0104	CbGbCtD
Etravirine—CYP3A4—Vinorelbine—hematologic cancer	0.00566	0.0103	CbGbCtD
Etravirine—CYP2C9—Cisplatin—hematologic cancer	0.00551	0.01	CbGbCtD
Etravirine—CYP2C19—Dexamethasone—hematologic cancer	0.00535	0.00975	CbGbCtD
Etravirine—ABCB1—Cisplatin—hematologic cancer	0.00534	0.00973	CbGbCtD
Etravirine—ABCB1—Etoposide—hematologic cancer	0.00525	0.00956	CbGbCtD
Etravirine—CYP3A4—Triamcinolone—hematologic cancer	0.00518	0.00944	CbGbCtD
Etravirine—CYP3A4—Dasatinib—hematologic cancer	0.00505	0.0092	CbGbCtD
Etravirine—CYP3A4—Mitoxantrone—hematologic cancer	0.00499	0.00909	CbGbCtD
Etravirine—CYP2C9—Dexamethasone—hematologic cancer	0.00445	0.0081	CbGbCtD
Etravirine—CYP3A4—Betamethasone—hematologic cancer	0.00445	0.0081	CbGbCtD
Etravirine—CYP3A4—Prednisolone—hematologic cancer	0.00439	0.00799	CbGbCtD
Etravirine—ABCB1—Dexamethasone—hematologic cancer	0.00432	0.00786	CbGbCtD
Etravirine—CYP3A4—Prednisone—hematologic cancer	0.00414	0.00755	CbGbCtD
Etravirine—ABCB4—hematopoietic system—hematologic cancer	0.00409	0.251	CbGeAlD
Etravirine—CYP3A4—Irinotecan—hematologic cancer	0.00393	0.00715	CbGbCtD
Etravirine—ABCB1—Doxorubicin—hematologic cancer	0.00358	0.00652	CbGbCtD
Etravirine—CYP3A4—Vinblastine—hematologic cancer	0.00349	0.00636	CbGbCtD
Etravirine—ABCB1—Methotrexate—hematologic cancer	0.00347	0.00632	CbGbCtD
Etravirine—CYP3A4—Vincristine—hematologic cancer	0.00343	0.00625	CbGbCtD
Etravirine—CYP3A4—Etoposide—hematologic cancer	0.00315	0.00573	CbGbCtD
Etravirine—ABCB4—blood—hematologic cancer	0.00271	0.166	CbGeAlD
Etravirine—CYP3A4—Dexamethasone—hematologic cancer	0.00259	0.00471	CbGbCtD
Etravirine—ABCB4—testis—hematologic cancer	0.00224	0.137	CbGeAlD
Etravirine—CYP3A4—Doxorubicin—hematologic cancer	0.00215	0.00391	CbGbCtD
Etravirine—ABCB4—lymph node—hematologic cancer	0.00162	0.0996	CbGeAlD
Etravirine—Rilpivirine—ABCG2—hematologic cancer	0.00153	0.706	CrCbGaD
Etravirine—CYP2C19—hematopoietic system—hematologic cancer	0.000965	0.0592	CbGeAlD
Etravirine—CYP2C9—hematopoietic system—hematologic cancer	0.000748	0.0459	CbGeAlD
Etravirine—CYP2C19—blood—hematologic cancer	0.000639	0.0392	CbGeAlD
Etravirine—Rilpivirine—ABCB1—hematologic cancer	0.000636	0.294	CrCbGaD
Etravirine—CYP3A4—hematopoietic system—hematologic cancer	0.000571	0.035	CbGeAlD
Etravirine—CYP2C9—blood—hematologic cancer	0.000496	0.0304	CbGeAlD
Etravirine—ABCB1—hematopoietic system—hematologic cancer	0.000404	0.0248	CbGeAlD
Etravirine—CYP3A4—blood—hematologic cancer	0.000378	0.0232	CbGeAlD
Etravirine—ABCB1—gonad—hematologic cancer	0.000307	0.0188	CbGeAlD
Etravirine—ABCB1—blood—hematologic cancer	0.000268	0.0164	CbGeAlD
Etravirine—ABCB1—bone marrow—hematologic cancer	0.000259	0.0159	CbGeAlD
Etravirine—ABCB1—lung—hematologic cancer	0.000235	0.0144	CbGeAlD
Etravirine—ABCB1—testis—hematologic cancer	0.000221	0.0136	CbGeAlD
Etravirine—ABCB1—lymph node—hematologic cancer	0.00016	0.00983	CbGeAlD
Etravirine—Nausea—Ifosfamide—hematologic cancer	3.22e-05	0.000133	CcSEcCtD
Etravirine—Feeling abnormal—Triamcinolone—hematologic cancer	3.2e-05	0.000133	CcSEcCtD
Etravirine—Diarrhoea—Cisplatin—hematologic cancer	3.19e-05	0.000132	CcSEcCtD
Etravirine—Erythema multiforme—Epirubicin—hematologic cancer	3.19e-05	0.000132	CcSEcCtD
Etravirine—Anxiety—Prednisone—hematologic cancer	3.19e-05	0.000132	CcSEcCtD
Etravirine—Vomiting—Gemcitabine—hematologic cancer	3.18e-05	0.000132	CcSEcCtD
Etravirine—Insomnia—Dexamethasone—hematologic cancer	3.18e-05	0.000132	CcSEcCtD
Etravirine—Insomnia—Betamethasone—hematologic cancer	3.18e-05	0.000132	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	3.17e-05	0.000132	CcSEcCtD
Etravirine—Paraesthesia—Betamethasone—hematologic cancer	3.16e-05	0.000131	CcSEcCtD
Etravirine—Paraesthesia—Dexamethasone—hematologic cancer	3.16e-05	0.000131	CcSEcCtD
Etravirine—Discomfort—Prednisone—hematologic cancer	3.16e-05	0.000131	CcSEcCtD
Etravirine—Mental disorder—Methotrexate—hematologic cancer	3.16e-05	0.000131	CcSEcCtD
Etravirine—Rash—Gemcitabine—hematologic cancer	3.16e-05	0.000131	CcSEcCtD
Etravirine—Dermatitis—Gemcitabine—hematologic cancer	3.15e-05	0.000131	CcSEcCtD
Etravirine—Eye disorder—Epirubicin—hematologic cancer	3.15e-05	0.000131	CcSEcCtD
Etravirine—Hypersensitivity—Etoposide—hematologic cancer	3.15e-05	0.000131	CcSEcCtD
Etravirine—Malnutrition—Methotrexate—hematologic cancer	3.14e-05	0.00013	CcSEcCtD
Etravirine—Headache—Gemcitabine—hematologic cancer	3.14e-05	0.00013	CcSEcCtD
Etravirine—Nausea—Vincristine—hematologic cancer	3.13e-05	0.00013	CcSEcCtD
Etravirine—Cardiac disorder—Epirubicin—hematologic cancer	3.13e-05	0.00013	CcSEcCtD
Etravirine—Hepatitis—Doxorubicin—hematologic cancer	3.12e-05	0.000129	CcSEcCtD
Etravirine—Hypersensitivity—Prednisolone—hematologic cancer	3.11e-05	0.000129	CcSEcCtD
Etravirine—Hypoaesthesia—Doxorubicin—hematologic cancer	3.11e-05	0.000129	CcSEcCtD
Etravirine—Urinary tract disorder—Doxorubicin—hematologic cancer	3.08e-05	0.000128	CcSEcCtD
Etravirine—Asthenia—Etoposide—hematologic cancer	3.07e-05	0.000127	CcSEcCtD
Etravirine—Connective tissue disorder—Doxorubicin—hematologic cancer	3.07e-05	0.000127	CcSEcCtD
Etravirine—Body temperature increased—Triamcinolone—hematologic cancer	3.07e-05	0.000127	CcSEcCtD
Etravirine—Angiopathy—Epirubicin—hematologic cancer	3.06e-05	0.000127	CcSEcCtD
Etravirine—Urethral disorder—Doxorubicin—hematologic cancer	3.06e-05	0.000127	CcSEcCtD
Etravirine—Decreased appetite—Dexamethasone—hematologic cancer	3.06e-05	0.000127	CcSEcCtD
Etravirine—Decreased appetite—Betamethasone—hematologic cancer	3.06e-05	0.000127	CcSEcCtD
Etravirine—Nausea—Irinotecan—hematologic cancer	3.05e-05	0.000127	CcSEcCtD
Etravirine—Nausea—Mitoxantrone—hematologic cancer	3.05e-05	0.000127	CcSEcCtD
Etravirine—Immune system disorder—Epirubicin—hematologic cancer	3.05e-05	0.000126	CcSEcCtD
Etravirine—Infection—Prednisone—hematologic cancer	3.04e-05	0.000126	CcSEcCtD
Etravirine—Mediastinal disorder—Epirubicin—hematologic cancer	3.04e-05	0.000126	CcSEcCtD
Etravirine—Gastrointestinal disorder—Betamethasone—hematologic cancer	3.04e-05	0.000126	CcSEcCtD
Etravirine—Gastrointestinal disorder—Dexamethasone—hematologic cancer	3.04e-05	0.000126	CcSEcCtD
Etravirine—Fatigue—Betamethasone—hematologic cancer	3.03e-05	0.000126	CcSEcCtD
Etravirine—Fatigue—Dexamethasone—hematologic cancer	3.03e-05	0.000126	CcSEcCtD
Etravirine—Shock—Prednisone—hematologic cancer	3.01e-05	0.000125	CcSEcCtD
Etravirine—Pain—Dexamethasone—hematologic cancer	3.01e-05	0.000125	CcSEcCtD
Etravirine—Pain—Betamethasone—hematologic cancer	3.01e-05	0.000125	CcSEcCtD
Etravirine—Nervous system disorder—Prednisone—hematologic cancer	3.01e-05	0.000125	CcSEcCtD
Etravirine—Skin disorder—Prednisone—hematologic cancer	2.98e-05	0.000123	CcSEcCtD
Etravirine—Nausea—Gemcitabine—hematologic cancer	2.97e-05	0.000123	CcSEcCtD
Etravirine—Vomiting—Cisplatin—hematologic cancer	2.97e-05	0.000123	CcSEcCtD
Etravirine—Hyperhidrosis—Prednisone—hematologic cancer	2.96e-05	0.000123	CcSEcCtD
Etravirine—Vision blurred—Methotrexate—hematologic cancer	2.96e-05	0.000123	CcSEcCtD
Etravirine—Mental disorder—Epirubicin—hematologic cancer	2.96e-05	0.000123	CcSEcCtD
Etravirine—Erythema multiforme—Doxorubicin—hematologic cancer	2.95e-05	0.000122	CcSEcCtD
Etravirine—Rash—Cisplatin—hematologic cancer	2.94e-05	0.000122	CcSEcCtD
Etravirine—Dermatitis—Cisplatin—hematologic cancer	2.94e-05	0.000122	CcSEcCtD
Etravirine—Malnutrition—Epirubicin—hematologic cancer	2.94e-05	0.000122	CcSEcCtD
Etravirine—Diarrhoea—Etoposide—hematologic cancer	2.93e-05	0.000121	CcSEcCtD
Etravirine—Anorexia—Prednisone—hematologic cancer	2.92e-05	0.000121	CcSEcCtD
Etravirine—Eye disorder—Doxorubicin—hematologic cancer	2.92e-05	0.000121	CcSEcCtD
Etravirine—Ill-defined disorder—Methotrexate—hematologic cancer	2.91e-05	0.000121	CcSEcCtD
Etravirine—Anaemia—Methotrexate—hematologic cancer	2.9e-05	0.00012	CcSEcCtD
Etravirine—Feeling abnormal—Dexamethasone—hematologic cancer	2.9e-05	0.00012	CcSEcCtD
Etravirine—Feeling abnormal—Betamethasone—hematologic cancer	2.9e-05	0.00012	CcSEcCtD
Etravirine—Cardiac disorder—Doxorubicin—hematologic cancer	2.9e-05	0.00012	CcSEcCtD
Etravirine—Flatulence—Epirubicin—hematologic cancer	2.89e-05	0.00012	CcSEcCtD
Etravirine—Tension—Epirubicin—hematologic cancer	2.88e-05	0.00012	CcSEcCtD
Etravirine—Gastrointestinal pain—Betamethasone—hematologic cancer	2.88e-05	0.000119	CcSEcCtD
Etravirine—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.88e-05	0.000119	CcSEcCtD
Etravirine—Hypersensitivity—Triamcinolone—hematologic cancer	2.86e-05	0.000118	CcSEcCtD
Etravirine—Nervousness—Epirubicin—hematologic cancer	2.85e-05	0.000118	CcSEcCtD
Etravirine—Angiopathy—Doxorubicin—hematologic cancer	2.83e-05	0.000117	CcSEcCtD
Etravirine—Malaise—Methotrexate—hematologic cancer	2.83e-05	0.000117	CcSEcCtD
Etravirine—Dizziness—Etoposide—hematologic cancer	2.83e-05	0.000117	CcSEcCtD
Etravirine—Immune system disorder—Doxorubicin—hematologic cancer	2.82e-05	0.000117	CcSEcCtD
Etravirine—Vertigo—Methotrexate—hematologic cancer	2.82e-05	0.000117	CcSEcCtD
Etravirine—Mediastinal disorder—Doxorubicin—hematologic cancer	2.81e-05	0.000117	CcSEcCtD
Etravirine—Dizziness—Prednisolone—hematologic cancer	2.79e-05	0.000116	CcSEcCtD
Etravirine—Asthenia—Triamcinolone—hematologic cancer	2.78e-05	0.000115	CcSEcCtD
Etravirine—Body temperature increased—Dexamethasone—hematologic cancer	2.78e-05	0.000115	CcSEcCtD
Etravirine—Abdominal pain—Betamethasone—hematologic cancer	2.78e-05	0.000115	CcSEcCtD
Etravirine—Abdominal pain—Dexamethasone—hematologic cancer	2.78e-05	0.000115	CcSEcCtD
Etravirine—Body temperature increased—Betamethasone—hematologic cancer	2.78e-05	0.000115	CcSEcCtD
Etravirine—Nausea—Cisplatin—hematologic cancer	2.77e-05	0.000115	CcSEcCtD
Etravirine—Insomnia—Prednisone—hematologic cancer	2.77e-05	0.000115	CcSEcCtD
Etravirine—Vision blurred—Epirubicin—hematologic cancer	2.77e-05	0.000115	CcSEcCtD
Etravirine—Paraesthesia—Prednisone—hematologic cancer	2.75e-05	0.000114	CcSEcCtD
Etravirine—Mental disorder—Doxorubicin—hematologic cancer	2.73e-05	0.000113	CcSEcCtD
Etravirine—Ill-defined disorder—Epirubicin—hematologic cancer	2.72e-05	0.000113	CcSEcCtD
Etravirine—Convulsion—Methotrexate—hematologic cancer	2.72e-05	0.000113	CcSEcCtD
Etravirine—Vomiting—Etoposide—hematologic cancer	2.72e-05	0.000113	CcSEcCtD
Etravirine—Malnutrition—Doxorubicin—hematologic cancer	2.72e-05	0.000113	CcSEcCtD
Etravirine—Anaemia—Epirubicin—hematologic cancer	2.71e-05	0.000113	CcSEcCtD
Etravirine—Rash—Etoposide—hematologic cancer	2.7e-05	0.000112	CcSEcCtD
Etravirine—Dermatitis—Etoposide—hematologic cancer	2.69e-05	0.000112	CcSEcCtD
Etravirine—Headache—Etoposide—hematologic cancer	2.68e-05	0.000111	CcSEcCtD
Etravirine—Flatulence—Doxorubicin—hematologic cancer	2.68e-05	0.000111	CcSEcCtD
Etravirine—Tension—Doxorubicin—hematologic cancer	2.67e-05	0.000111	CcSEcCtD
Etravirine—Decreased appetite—Prednisone—hematologic cancer	2.66e-05	0.00011	CcSEcCtD
Etravirine—Rash—Prednisolone—hematologic cancer	2.66e-05	0.00011	CcSEcCtD
Etravirine—Dermatitis—Prednisolone—hematologic cancer	2.66e-05	0.00011	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.65e-05	0.00011	CcSEcCtD
Etravirine—Malaise—Epirubicin—hematologic cancer	2.65e-05	0.00011	CcSEcCtD
Etravirine—Fatigue—Prednisone—hematologic cancer	2.64e-05	0.00011	CcSEcCtD
Etravirine—Headache—Prednisolone—hematologic cancer	2.64e-05	0.00011	CcSEcCtD
Etravirine—Discomfort—Methotrexate—hematologic cancer	2.64e-05	0.000109	CcSEcCtD
Etravirine—Nervousness—Doxorubicin—hematologic cancer	2.64e-05	0.000109	CcSEcCtD
Etravirine—Vertigo—Epirubicin—hematologic cancer	2.64e-05	0.000109	CcSEcCtD
Etravirine—Syncope—Epirubicin—hematologic cancer	2.63e-05	0.000109	CcSEcCtD
Etravirine—Constipation—Prednisone—hematologic cancer	2.62e-05	0.000109	CcSEcCtD
Etravirine—Confusional state—Methotrexate—hematologic cancer	2.58e-05	0.000107	CcSEcCtD
Etravirine—Loss of consciousness—Epirubicin—hematologic cancer	2.58e-05	0.000107	CcSEcCtD
Etravirine—Dizziness—Triamcinolone—hematologic cancer	2.56e-05	0.000106	CcSEcCtD
Etravirine—Vision blurred—Doxorubicin—hematologic cancer	2.56e-05	0.000106	CcSEcCtD
Etravirine—Convulsion—Epirubicin—hematologic cancer	2.54e-05	0.000106	CcSEcCtD
Etravirine—Infection—Methotrexate—hematologic cancer	2.54e-05	0.000106	CcSEcCtD
Etravirine—Nausea—Etoposide—hematologic cancer	2.54e-05	0.000105	CcSEcCtD
Etravirine—Hypertension—Epirubicin—hematologic cancer	2.54e-05	0.000105	CcSEcCtD
Etravirine—Feeling abnormal—Prednisone—hematologic cancer	2.53e-05	0.000105	CcSEcCtD
Etravirine—Asthenia—Betamethasone—hematologic cancer	2.52e-05	0.000105	CcSEcCtD
Etravirine—Asthenia—Dexamethasone—hematologic cancer	2.52e-05	0.000105	CcSEcCtD
Etravirine—Ill-defined disorder—Doxorubicin—hematologic cancer	2.52e-05	0.000105	CcSEcCtD
Etravirine—Nervous system disorder—Methotrexate—hematologic cancer	2.51e-05	0.000104	CcSEcCtD
Etravirine—Anaemia—Doxorubicin—hematologic cancer	2.51e-05	0.000104	CcSEcCtD
Etravirine—Thrombocytopenia—Methotrexate—hematologic cancer	2.51e-05	0.000104	CcSEcCtD
Etravirine—Gastrointestinal pain—Prednisone—hematologic cancer	2.51e-05	0.000104	CcSEcCtD
Etravirine—Nausea—Prednisolone—hematologic cancer	2.5e-05	0.000104	CcSEcCtD
Etravirine—Anxiety—Epirubicin—hematologic cancer	2.49e-05	0.000103	CcSEcCtD
Etravirine—Skin disorder—Methotrexate—hematologic cancer	2.49e-05	0.000103	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.48e-05	0.000103	CcSEcCtD
Etravirine—Hyperhidrosis—Methotrexate—hematologic cancer	2.48e-05	0.000103	CcSEcCtD
Etravirine—Discomfort—Epirubicin—hematologic cancer	2.47e-05	0.000102	CcSEcCtD
Etravirine—Vomiting—Triamcinolone—hematologic cancer	2.47e-05	0.000102	CcSEcCtD
Etravirine—Malaise—Doxorubicin—hematologic cancer	2.45e-05	0.000102	CcSEcCtD
Etravirine—Rash—Triamcinolone—hematologic cancer	2.45e-05	0.000101	CcSEcCtD
Etravirine—Dry mouth—Epirubicin—hematologic cancer	2.44e-05	0.000101	CcSEcCtD
Etravirine—Dermatitis—Triamcinolone—hematologic cancer	2.44e-05	0.000101	CcSEcCtD
Etravirine—Vertigo—Doxorubicin—hematologic cancer	2.44e-05	0.000101	CcSEcCtD
Etravirine—Anorexia—Methotrexate—hematologic cancer	2.44e-05	0.000101	CcSEcCtD
Etravirine—Syncope—Doxorubicin—hematologic cancer	2.44e-05	0.000101	CcSEcCtD
Etravirine—Headache—Triamcinolone—hematologic cancer	2.43e-05	0.000101	CcSEcCtD
Etravirine—Abdominal pain—Prednisone—hematologic cancer	2.42e-05	0.0001	CcSEcCtD
Etravirine—Body temperature increased—Prednisone—hematologic cancer	2.42e-05	0.0001	CcSEcCtD
Etravirine—Confusional state—Epirubicin—hematologic cancer	2.42e-05	0.0001	CcSEcCtD
Etravirine—Diarrhoea—Dexamethasone—hematologic cancer	2.41e-05	9.98e-05	CcSEcCtD
Etravirine—Diarrhoea—Betamethasone—hematologic cancer	2.41e-05	9.98e-05	CcSEcCtD
Etravirine—Loss of consciousness—Doxorubicin—hematologic cancer	2.39e-05	9.9e-05	CcSEcCtD
Etravirine—Infection—Epirubicin—hematologic cancer	2.38e-05	9.87e-05	CcSEcCtD
Etravirine—Shock—Epirubicin—hematologic cancer	2.36e-05	9.78e-05	CcSEcCtD
Etravirine—Convulsion—Doxorubicin—hematologic cancer	2.35e-05	9.76e-05	CcSEcCtD
Etravirine—Nervous system disorder—Epirubicin—hematologic cancer	2.35e-05	9.75e-05	CcSEcCtD
Etravirine—Thrombocytopenia—Epirubicin—hematologic cancer	2.35e-05	9.73e-05	CcSEcCtD
Etravirine—Hypertension—Doxorubicin—hematologic cancer	2.35e-05	9.73e-05	CcSEcCtD
Etravirine—Skin disorder—Epirubicin—hematologic cancer	2.33e-05	9.65e-05	CcSEcCtD
Etravirine—Dizziness—Dexamethasone—hematologic cancer	2.33e-05	9.65e-05	CcSEcCtD
Etravirine—Dizziness—Betamethasone—hematologic cancer	2.33e-05	9.65e-05	CcSEcCtD
Etravirine—Hyperhidrosis—Epirubicin—hematologic cancer	2.32e-05	9.61e-05	CcSEcCtD
Etravirine—Insomnia—Methotrexate—hematologic cancer	2.32e-05	9.61e-05	CcSEcCtD
Etravirine—Anxiety—Doxorubicin—hematologic cancer	2.31e-05	9.56e-05	CcSEcCtD
Etravirine—Nausea—Triamcinolone—hematologic cancer	2.3e-05	9.55e-05	CcSEcCtD
Etravirine—Paraesthesia—Methotrexate—hematologic cancer	2.3e-05	9.54e-05	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.3e-05	9.53e-05	CcSEcCtD
Etravirine—Discomfort—Doxorubicin—hematologic cancer	2.29e-05	9.48e-05	CcSEcCtD
Etravirine—Anorexia—Epirubicin—hematologic cancer	2.28e-05	9.47e-05	CcSEcCtD
Etravirine—Somnolence—Methotrexate—hematologic cancer	2.28e-05	9.44e-05	CcSEcCtD
Etravirine—Dry mouth—Doxorubicin—hematologic cancer	2.26e-05	9.38e-05	CcSEcCtD
Etravirine—Hypersensitivity—Prednisone—hematologic cancer	2.26e-05	9.36e-05	CcSEcCtD
Etravirine—Vomiting—Betamethasone—hematologic cancer	2.24e-05	9.28e-05	CcSEcCtD
Etravirine—Vomiting—Dexamethasone—hematologic cancer	2.24e-05	9.28e-05	CcSEcCtD
Etravirine—Confusional state—Doxorubicin—hematologic cancer	2.24e-05	9.27e-05	CcSEcCtD
Etravirine—Decreased appetite—Methotrexate—hematologic cancer	2.23e-05	9.23e-05	CcSEcCtD
Etravirine—Rash—Dexamethasone—hematologic cancer	2.22e-05	9.2e-05	CcSEcCtD
Etravirine—Rash—Betamethasone—hematologic cancer	2.22e-05	9.2e-05	CcSEcCtD
Etravirine—Dermatitis—Dexamethasone—hematologic cancer	2.22e-05	9.19e-05	CcSEcCtD
Etravirine—Dermatitis—Betamethasone—hematologic cancer	2.22e-05	9.19e-05	CcSEcCtD
Etravirine—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.21e-05	9.17e-05	CcSEcCtD
Etravirine—Fatigue—Methotrexate—hematologic cancer	2.21e-05	9.16e-05	CcSEcCtD
Etravirine—Headache—Betamethasone—hematologic cancer	2.2e-05	9.14e-05	CcSEcCtD
Etravirine—Headache—Dexamethasone—hematologic cancer	2.2e-05	9.14e-05	CcSEcCtD
Etravirine—Infection—Doxorubicin—hematologic cancer	2.2e-05	9.14e-05	CcSEcCtD
Etravirine—Asthenia—Prednisone—hematologic cancer	2.2e-05	9.12e-05	CcSEcCtD
Etravirine—Pain—Methotrexate—hematologic cancer	2.19e-05	9.08e-05	CcSEcCtD
Etravirine—Shock—Doxorubicin—hematologic cancer	2.18e-05	9.05e-05	CcSEcCtD
Etravirine—Nervous system disorder—Doxorubicin—hematologic cancer	2.17e-05	9.02e-05	CcSEcCtD
Etravirine—Thrombocytopenia—Doxorubicin—hematologic cancer	2.17e-05	9e-05	CcSEcCtD
Etravirine—Insomnia—Epirubicin—hematologic cancer	2.17e-05	8.99e-05	CcSEcCtD
Etravirine—Skin disorder—Doxorubicin—hematologic cancer	2.15e-05	8.93e-05	CcSEcCtD
Etravirine—Paraesthesia—Epirubicin—hematologic cancer	2.15e-05	8.92e-05	CcSEcCtD
Etravirine—Hyperhidrosis—Doxorubicin—hematologic cancer	2.14e-05	8.89e-05	CcSEcCtD
Etravirine—Somnolence—Epirubicin—hematologic cancer	2.13e-05	8.84e-05	CcSEcCtD
Etravirine—Anorexia—Doxorubicin—hematologic cancer	2.11e-05	8.77e-05	CcSEcCtD
Etravirine—Feeling abnormal—Methotrexate—hematologic cancer	2.11e-05	8.75e-05	CcSEcCtD
Etravirine—Diarrhoea—Prednisone—hematologic cancer	2.1e-05	8.7e-05	CcSEcCtD
Etravirine—Gastrointestinal pain—Methotrexate—hematologic cancer	2.09e-05	8.68e-05	CcSEcCtD
Etravirine—Nausea—Dexamethasone—hematologic cancer	2.09e-05	8.67e-05	CcSEcCtD
Etravirine—Nausea—Betamethasone—hematologic cancer	2.09e-05	8.67e-05	CcSEcCtD
Etravirine—Decreased appetite—Epirubicin—hematologic cancer	2.08e-05	8.64e-05	CcSEcCtD
Etravirine—Gastrointestinal disorder—Epirubicin—hematologic cancer	2.07e-05	8.58e-05	CcSEcCtD
Etravirine—Fatigue—Epirubicin—hematologic cancer	2.07e-05	8.57e-05	CcSEcCtD
Etravirine—Constipation—Epirubicin—hematologic cancer	2.05e-05	8.5e-05	CcSEcCtD
Etravirine—Pain—Epirubicin—hematologic cancer	2.05e-05	8.5e-05	CcSEcCtD
Etravirine—Dizziness—Prednisone—hematologic cancer	2.03e-05	8.4e-05	CcSEcCtD
Etravirine—Abdominal pain—Methotrexate—hematologic cancer	2.02e-05	8.4e-05	CcSEcCtD
Etravirine—Body temperature increased—Methotrexate—hematologic cancer	2.02e-05	8.4e-05	CcSEcCtD
Etravirine—Insomnia—Doxorubicin—hematologic cancer	2.01e-05	8.32e-05	CcSEcCtD
Etravirine—Paraesthesia—Doxorubicin—hematologic cancer	1.99e-05	8.26e-05	CcSEcCtD
Etravirine—Feeling abnormal—Epirubicin—hematologic cancer	1.97e-05	8.19e-05	CcSEcCtD
Etravirine—Somnolence—Doxorubicin—hematologic cancer	1.97e-05	8.18e-05	CcSEcCtD
Etravirine—Gastrointestinal pain—Epirubicin—hematologic cancer	1.96e-05	8.13e-05	CcSEcCtD
Etravirine—Vomiting—Prednisone—hematologic cancer	1.95e-05	8.08e-05	CcSEcCtD
Etravirine—Rash—Prednisone—hematologic cancer	1.93e-05	8.01e-05	CcSEcCtD
Etravirine—Dermatitis—Prednisone—hematologic cancer	1.93e-05	8.01e-05	CcSEcCtD
Etravirine—Decreased appetite—Doxorubicin—hematologic cancer	1.93e-05	7.99e-05	CcSEcCtD
Etravirine—Headache—Prednisone—hematologic cancer	1.92e-05	7.96e-05	CcSEcCtD
Etravirine—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.91e-05	7.94e-05	CcSEcCtD
Etravirine—Fatigue—Doxorubicin—hematologic cancer	1.91e-05	7.93e-05	CcSEcCtD
Etravirine—Pain—Doxorubicin—hematologic cancer	1.9e-05	7.86e-05	CcSEcCtD
Etravirine—Constipation—Doxorubicin—hematologic cancer	1.9e-05	7.86e-05	CcSEcCtD
Etravirine—Body temperature increased—Epirubicin—hematologic cancer	1.89e-05	7.86e-05	CcSEcCtD
Etravirine—Abdominal pain—Epirubicin—hematologic cancer	1.89e-05	7.86e-05	CcSEcCtD
Etravirine—Hypersensitivity—Methotrexate—hematologic cancer	1.89e-05	7.82e-05	CcSEcCtD
Etravirine—Asthenia—Methotrexate—hematologic cancer	1.84e-05	7.62e-05	CcSEcCtD
Etravirine—Feeling abnormal—Doxorubicin—hematologic cancer	1.83e-05	7.58e-05	CcSEcCtD
Etravirine—Nausea—Prednisone—hematologic cancer	1.82e-05	7.55e-05	CcSEcCtD
Etravirine—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.81e-05	7.52e-05	CcSEcCtD
Etravirine—Hypersensitivity—Epirubicin—hematologic cancer	1.77e-05	7.32e-05	CcSEcCtD
Etravirine—Body temperature increased—Doxorubicin—hematologic cancer	1.75e-05	7.27e-05	CcSEcCtD
Etravirine—Abdominal pain—Doxorubicin—hematologic cancer	1.75e-05	7.27e-05	CcSEcCtD
Etravirine—Diarrhoea—Methotrexate—hematologic cancer	1.75e-05	7.27e-05	CcSEcCtD
Etravirine—Asthenia—Epirubicin—hematologic cancer	1.72e-05	7.13e-05	CcSEcCtD
Etravirine—Dizziness—Methotrexate—hematologic cancer	1.69e-05	7.02e-05	CcSEcCtD
Etravirine—Diarrhoea—Epirubicin—hematologic cancer	1.64e-05	6.8e-05	CcSEcCtD
Etravirine—Hypersensitivity—Doxorubicin—hematologic cancer	1.63e-05	6.78e-05	CcSEcCtD
Etravirine—Vomiting—Methotrexate—hematologic cancer	1.63e-05	6.75e-05	CcSEcCtD
Etravirine—Rash—Methotrexate—hematologic cancer	1.61e-05	6.7e-05	CcSEcCtD
Etravirine—Dermatitis—Methotrexate—hematologic cancer	1.61e-05	6.69e-05	CcSEcCtD
Etravirine—Headache—Methotrexate—hematologic cancer	1.6e-05	6.65e-05	CcSEcCtD
Etravirine—Asthenia—Doxorubicin—hematologic cancer	1.59e-05	6.6e-05	CcSEcCtD
Etravirine—Dizziness—Epirubicin—hematologic cancer	1.58e-05	6.57e-05	CcSEcCtD
Etravirine—Vomiting—Epirubicin—hematologic cancer	1.52e-05	6.32e-05	CcSEcCtD
Etravirine—Nausea—Methotrexate—hematologic cancer	1.52e-05	6.31e-05	CcSEcCtD
Etravirine—Diarrhoea—Doxorubicin—hematologic cancer	1.52e-05	6.29e-05	CcSEcCtD
Etravirine—Rash—Epirubicin—hematologic cancer	1.51e-05	6.27e-05	CcSEcCtD
Etravirine—Dermatitis—Epirubicin—hematologic cancer	1.51e-05	6.26e-05	CcSEcCtD
Etravirine—Headache—Epirubicin—hematologic cancer	1.5e-05	6.23e-05	CcSEcCtD
Etravirine—CYP2C19—Metabolism—SLC35B2—hematologic cancer	1.48e-05	0.000281	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GBA—hematologic cancer	1.48e-05	0.000281	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	1.48e-05	0.000281	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.47e-05	0.000279	CbGpPWpGaD
Etravirine—Dizziness—Doxorubicin—hematologic cancer	1.47e-05	6.08e-05	CcSEcCtD
Etravirine—CYP2C9—Metabolism—CDA—hematologic cancer	1.45e-05	0.000276	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.45e-05	0.000275	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.45e-05	0.000274	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GBA—hematologic cancer	1.45e-05	0.000274	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.45e-05	0.000274	CbGpPWpGaD
Etravirine—Nausea—Epirubicin—hematologic cancer	1.42e-05	5.9e-05	CcSEcCtD
Etravirine—Vomiting—Doxorubicin—hematologic cancer	1.41e-05	5.85e-05	CcSEcCtD
Etravirine—CYP2C9—Metabolism—PC—hematologic cancer	1.4e-05	0.000265	CbGpPWpGaD
Etravirine—Rash—Doxorubicin—hematologic cancer	1.4e-05	5.8e-05	CcSEcCtD
Etravirine—Dermatitis—Doxorubicin—hematologic cancer	1.4e-05	5.79e-05	CcSEcCtD
Etravirine—Headache—Doxorubicin—hematologic cancer	1.39e-05	5.76e-05	CcSEcCtD
Etravirine—CYP3A4—Metabolism—PHYH—hematologic cancer	1.38e-05	0.000262	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—FTCD—hematologic cancer	1.38e-05	0.000262	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GMPS—hematologic cancer	1.38e-05	0.000262	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTAP—hematologic cancer	1.36e-05	0.000257	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC35B2—hematologic cancer	1.35e-05	0.000256	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GBA—hematologic cancer	1.35e-05	0.000256	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTAP—hematologic cancer	1.32e-05	0.000251	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.32e-05	0.000251	CbGpPWpGaD
Etravirine—Nausea—Doxorubicin—hematologic cancer	1.32e-05	5.46e-05	CcSEcCtD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.3e-05	0.000246	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SMPD3—hematologic cancer	1.27e-05	0.00024	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.26e-05	0.000239	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.26e-05	0.000239	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—PIK3CA—hematologic cancer	1.24e-05	0.000235	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTAP—hematologic cancer	1.24e-05	0.000234	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.22e-05	0.000231	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.22e-05	0.000231	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.21e-05	0.00023	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—FHL2—hematologic cancer	1.21e-05	0.000229	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.19e-05	0.000226	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AGRN—hematologic cancer	1.19e-05	0.000225	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—FHL2—hematologic cancer	1.18e-05	0.000224	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.16e-05	0.00022	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AGRN—hematologic cancer	1.16e-05	0.000219	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.13e-05	0.000214	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—IDH2—hematologic cancer	1.12e-05	0.000213	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HMMR—hematologic cancer	1.12e-05	0.000213	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—B3GAT1—hematologic cancer	1.11e-05	0.00021	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ASNS—hematologic cancer	1.11e-05	0.00021	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—DCK—hematologic cancer	1.11e-05	0.00021	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—FHL2—hematologic cancer	1.1e-05	0.000209	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.1e-05	0.000208	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HMMR—hematologic cancer	1.1e-05	0.000208	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—IDH2—hematologic cancer	1.1e-05	0.000208	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AGRN—hematologic cancer	1.08e-05	0.000205	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	1.06e-05	0.000201	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ARNTL—hematologic cancer	1.06e-05	0.0002	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HDC—hematologic cancer	1.05e-05	0.000199	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.04e-05	0.000197	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ARNTL—hematologic cancer	1.03e-05	0.000195	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CA9—hematologic cancer	1.03e-05	0.000195	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ACP5—hematologic cancer	1.03e-05	0.000195	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HMMR—hematologic cancer	1.02e-05	0.000194	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—IDH2—hematologic cancer	1.02e-05	0.000194	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOR2—hematologic cancer	1.01e-05	0.000192	CbGpPWpGaD
Etravirine—ABCB4—Metabolism—AKT1—hematologic cancer	1.01e-05	0.000192	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.01e-05	0.000192	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.01e-05	0.000191	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CA9—hematologic cancer	1e-05	0.00019	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ACP5—hematologic cancer	1e-05	0.00019	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOR2—hematologic cancer	9.9e-06	0.000188	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—IDH1—hematologic cancer	9.66e-06	0.000183	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	9.66e-06	0.000183	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ARNTL—hematologic cancer	9.63e-06	0.000183	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CDA—hematologic cancer	9.59e-06	0.000182	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—TXN—hematologic cancer	9.56e-06	0.000181	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCC3—hematologic cancer	9.56e-06	0.000181	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTO1—hematologic cancer	9.56e-06	0.000181	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—IDH1—hematologic cancer	9.43e-06	0.000179	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	9.43e-06	0.000179	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ACP5—hematologic cancer	9.37e-06	0.000178	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CA9—hematologic cancer	9.37e-06	0.000178	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	9.35e-06	0.000177	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SPHK1—hematologic cancer	9.35e-06	0.000177	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTO1—hematologic cancer	9.33e-06	0.000177	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ABCC3—hematologic cancer	9.33e-06	0.000177	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—TXN—hematologic cancer	9.33e-06	0.000177	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOR2—hematologic cancer	9.25e-06	0.000175	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PC—hematologic cancer	9.23e-06	0.000175	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SPHK1—hematologic cancer	9.13e-06	0.000173	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—UGT1A1—hematologic cancer	8.98e-06	0.00017	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC35B2—hematologic cancer	8.92e-06	0.000169	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GBA—hematologic cancer	8.92e-06	0.000169	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—IDH1—hematologic cancer	8.81e-06	0.000167	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—UGT1A1—hematologic cancer	8.77e-06	0.000166	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SLC22A1—hematologic cancer	8.74e-06	0.000166	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CRABP1—hematologic cancer	8.74e-06	0.000166	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTO1—hematologic cancer	8.71e-06	0.000165	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCC3—hematologic cancer	8.71e-06	0.000165	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—TXN—hematologic cancer	8.71e-06	0.000165	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	8.59e-06	0.000163	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SLC22A1—hematologic cancer	8.53e-06	0.000162	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CRABP1—hematologic cancer	8.53e-06	0.000162	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SPHK1—hematologic cancer	8.53e-06	0.000162	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALOX5—hematologic cancer	8.52e-06	0.000161	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALOX5—hematologic cancer	8.31e-06	0.000158	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	8.31e-06	0.000158	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NUP98—hematologic cancer	8.25e-06	0.000156	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—UGT1A1—hematologic cancer	8.19e-06	0.000155	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTAP—hematologic cancer	8.16e-06	0.000155	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NUP98—hematologic cancer	8.05e-06	0.000153	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ADCY7—hematologic cancer	8.01e-06	0.000152	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOA3—hematologic cancer	8.01e-06	0.000152	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SLC22A1—hematologic cancer	7.97e-06	0.000151	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CRABP1—hematologic cancer	7.97e-06	0.000151	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NUP214—hematologic cancer	7.95e-06	0.000151	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.87e-06	0.000149	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ADCY7—hematologic cancer	7.82e-06	0.000148	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOA3—hematologic cancer	7.82e-06	0.000148	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTR—hematologic cancer	7.79e-06	0.000148	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCG2—hematologic cancer	7.79e-06	0.000148	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALOX5—hematologic cancer	7.77e-06	0.000147	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NUP214—hematologic cancer	7.76e-06	0.000147	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ENO2—hematologic cancer	7.64e-06	0.000145	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ABCG2—hematologic cancer	7.6e-06	0.000144	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTR—hematologic cancer	7.6e-06	0.000144	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NUP98—hematologic cancer	7.52e-06	0.000143	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ENO2—hematologic cancer	7.46e-06	0.000141	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTT1—hematologic cancer	7.41e-06	0.00014	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ADCY7—hematologic cancer	7.3e-06	0.000138	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOA3—hematologic cancer	7.3e-06	0.000138	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	7.3e-06	0.000138	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—FHL2—hematologic cancer	7.27e-06	0.000138	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NUP214—hematologic cancer	7.25e-06	0.000137	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—SDC1—hematologic cancer	7.24e-06	0.000137	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTT1—hematologic cancer	7.23e-06	0.000137	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	7.17e-06	0.000136	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AGRN—hematologic cancer	7.13e-06	0.000135	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTR—hematologic cancer	7.1e-06	0.000135	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCG2—hematologic cancer	7.1e-06	0.000135	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—SDC1—hematologic cancer	7.07e-06	0.000134	CbGpPWpGaD
Etravirine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	7.02e-06	0.000133	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ENO2—hematologic cancer	6.97e-06	0.000132	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.92e-06	0.000131	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.83e-06	0.000129	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	6.77e-06	0.000128	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—IDH2—hematologic cancer	6.76e-06	0.000128	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HMMR—hematologic cancer	6.76e-06	0.000128	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTT1—hematologic cancer	6.76e-06	0.000128	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	6.65e-06	0.000126	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—SDC1—hematologic cancer	6.6e-06	0.000125	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	6.53e-06	0.000124	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ARNTL—hematologic cancer	6.35e-06	0.00012	CbGpPWpGaD
Etravirine—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	6.34e-06	0.00012	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	6.31e-06	0.00012	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	6.23e-06	0.000118	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ACP5—hematologic cancer	6.18e-06	0.000117	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CA9—hematologic cancer	6.18e-06	0.000117	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CD44—hematologic cancer	6.16e-06	0.000117	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NQO1—hematologic cancer	6.16e-06	0.000117	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOR2—hematologic cancer	6.1e-06	0.000116	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.03e-06	0.000114	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NQO1—hematologic cancer	6.01e-06	0.000114	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CD44—hematologic cancer	6.01e-06	0.000114	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	5.96e-06	0.000113	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CYCS—hematologic cancer	5.83e-06	0.00011	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—IDH1—hematologic cancer	5.81e-06	0.00011	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	5.79e-06	0.00011	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTO1—hematologic cancer	5.75e-06	0.000109	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCC3—hematologic cancer	5.75e-06	0.000109	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—TXN—hematologic cancer	5.75e-06	0.000109	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CYCS—hematologic cancer	5.69e-06	0.000108	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—HSP90AA1—hematologic cancer	5.65e-06	0.000107	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SPHK1—hematologic cancer	5.62e-06	0.000107	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NQO1—hematologic cancer	5.61e-06	0.000106	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CD44—hematologic cancer	5.61e-06	0.000106	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	5.5e-06	0.000104	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	5.4e-06	0.000102	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CYCS—hematologic cancer	5.31e-06	0.000101	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	5.28e-06	0.0001	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	5.26e-06	9.96e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CRABP1—hematologic cancer	5.26e-06	9.96e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.21e-06	9.88e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTP1—hematologic cancer	5.14e-06	9.73e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALOX5—hematologic cancer	5.12e-06	9.71e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTP1—hematologic cancer	5.01e-06	9.5e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.97e-06	9.42e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NUP98—hematologic cancer	4.96e-06	9.4e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ABCB1—hematologic cancer	4.86e-06	9.21e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ADCY7—hematologic cancer	4.82e-06	9.13e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOA3—hematologic cancer	4.82e-06	9.13e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NUP214—hematologic cancer	4.78e-06	9.06e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	4.75e-06	9e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—GSTM1—hematologic cancer	4.72e-06	8.95e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—NCOR1—hematologic cancer	4.72e-06	8.95e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCG2—hematologic cancer	4.68e-06	8.88e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTR—hematologic cancer	4.68e-06	8.88e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTP1—hematologic cancer	4.68e-06	8.88e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—GSTM1—hematologic cancer	4.61e-06	8.73e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—NCOR1—hematologic cancer	4.61e-06	8.73e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ENO2—hematologic cancer	4.59e-06	8.71e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	4.53e-06	8.59e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTT1—hematologic cancer	4.46e-06	8.44e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ABCB1—hematologic cancer	4.43e-06	8.4e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—SDC1—hematologic cancer	4.35e-06	8.25e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—GSTM1—hematologic cancer	4.3e-06	8.16e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—NCOR1—hematologic cancer	4.3e-06	8.16e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—MTHFR—hematologic cancer	4.17e-06	7.91e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—MTHFR—hematologic cancer	4.07e-06	7.72e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—MTHFR—hematologic cancer	3.8e-06	7.21e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CD44—hematologic cancer	3.7e-06	7.02e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NQO1—hematologic cancer	3.7e-06	7.02e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.68e-06	6.97e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	3.5e-06	6.64e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CYCS—hematologic cancer	3.5e-06	6.64e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	3.48e-06	6.6e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CG—hematologic cancer	3.42e-06	6.48e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.35e-06	6.35e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—CREBBP—hematologic cancer	3.25e-06	6.16e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CG—hematologic cancer	3.2e-06	6.06e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—CREBBP—hematologic cancer	3.17e-06	6.01e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTP1—hematologic cancer	3.09e-06	5.85e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	3.08e-06	5.84e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—ALB—hematologic cancer	3.04e-06	5.76e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.01e-06	5.7e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—ALB—hematologic cancer	2.97e-06	5.63e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—CREBBP—hematologic cancer	2.96e-06	5.62e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ABCB1—hematologic cancer	2.92e-06	5.54e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	2.91e-06	5.51e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3R1—hematologic cancer	2.84e-06	5.38e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—NCOR1—hematologic cancer	2.84e-06	5.38e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—GSTM1—hematologic cancer	2.84e-06	5.38e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CD—hematologic cancer	2.81e-06	5.32e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—ALB—hematologic cancer	2.77e-06	5.26e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	2.69e-06	5.09e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3R1—hematologic cancer	2.65e-06	5.03e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CB—hematologic cancer	2.62e-06	4.97e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—MTHFR—hematologic cancer	2.51e-06	4.75e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CB—hematologic cancer	2.45e-06	4.64e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PTEN—hematologic cancer	2.32e-06	4.4e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PTEN—hematologic cancer	2.26e-06	4.29e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—EP300—hematologic cancer	2.21e-06	4.19e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—EP300—hematologic cancer	2.16e-06	4.09e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PTEN—hematologic cancer	2.12e-06	4.01e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	2.11e-06	3.99e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—EP300—hematologic cancer	2.02e-06	3.82e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.95e-06	3.7e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.85e-06	3.51e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—ALB—hematologic cancer	1.83e-06	3.47e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.75e-06	3.32e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.64e-06	3.1e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.61e-06	3.06e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.6e-06	3.03e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—PIK3CA—hematologic cancer	1.49e-06	2.83e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PTEN—hematologic cancer	1.4e-06	2.64e-05	CbGpPWpGaD
Etravirine—CYP2C19—Metabolism—AKT1—hematologic cancer	1.34e-06	2.53e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—EP300—hematologic cancer	1.33e-06	2.52e-05	CbGpPWpGaD
Etravirine—ABCB1—Metabolism—AKT1—hematologic cancer	1.31e-06	2.47e-05	CbGpPWpGaD
Etravirine—CYP2C9—Metabolism—AKT1—hematologic cancer	1.22e-06	2.31e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	9.84e-07	1.87e-05	CbGpPWpGaD
Etravirine—CYP3A4—Metabolism—AKT1—hematologic cancer	8.04e-07	1.52e-05	CbGpPWpGaD
